Top compounds associated with response to CCDC157


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K44224150 CTRPv2 pan-cancer AAC 0.15 0.05
mRNA tamatinib CTRPv2 pan-cancer AAC -0.076 0.05
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.071 0.05
mRNA AT-7519 GDSC1000 pan-cancer AAC 0.056 0.05
mRNA neopeltolide CTRPv2 pan-cancer AAC 0.14 0.05
mRNA PX-12 CTRPv2 pan-cancer AAC 0.057 0.06
mRNA linifanib GDSC1000 pan-cancer AAC 0.065 0.06
mRNA BRD-K80183349 CTRPv2 pan-cancer AAC -0.064 0.06
mRNA WZ3105 GDSC1000 pan-cancer AAC 0.055 0.06
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.069 0.06
Download CSV